Oridonin Targets Multiple Drug-Resistant Tumor Cells as Determined by in Silico and in Vitro Analyses
Onat Kadioglu(Johannes Gutenberg University Mainz), Thomas Efferth(Johannes Gutenberg University Mainz)
Cited by 24
Related Papers
Natural products in drug discovery: advances and opportunities
|Nature Reviews Drug Discovery|2021|5k
The role of p53 in cancer drug resistance and targeted chemotherapy
|Oncotarget|2016|580
Best practice in research – Overcoming common challenges in phytopharmacological research
|Journal of Ethnopharmacology|2019|548
Evolution of the adaptogenic concept from traditional use to medical systems: Pharmacology of stress‐ and aging‐related diseases
|Medicinal Research Reviews|2020|328
Potential of Central, Eastern and Western Africa Medicinal Plants for Cancer Therapy: Spotlight on Resistant Cells and Molecular Targets
|Frontiers in Pharmacology|2017|142